Home › NCT06603051

The Effect of Pre-Operative Cryoneurolysis on Post-Operative Narcotic Consumption in Patients Undergoing Autograft ACL Reconstruction

Who can join

Ages 14 and older · All sexes

Inclusion Criteria:

* \- Patients aged 14 and over
* Patients who are patients within the PI's practice
* Patients who can speak and read English
* Patients undergoing autograft ACL reconstruction.
* Patients who are opioid naïve

Exclusion Criteria:

* \- Under the age of 14
* Non-English speaking/reading patients
* Patients with Reynauds' syndrome
* Patients with skin disorders or hypo-vascularity
* Patients undergoing allograft ACL reconstruction.
* Patients who consistently use opioids preoperatively

About the study

The purpose of the research is to investigate the effect of preoperative Cryoneurolysis of the knee on postoperative pain management in patients undergoing autograft anterior cruciate ligament (ACL) reconstruction (a surgical procedure that makes a new ACL using the patient's own tendon). Cryoneurolysis is an approved process of applying extreme cold temperatures to targeted nerves in order to decrease or eliminate pain. . If you take part in the research, you will be randomly assigned (assigned by chance, like a flip of a coin) to Group A (standard care) or Group B (standard care plus Cryoneurolysis). Participants in both groups will undergo standard ACL reconstruction and receive standard preoperative and postoperative pain management. Participants in Group B only will also receive a standard treatment of Cryoneurolysis to their surgical knee within 7-10 days before their scheduled surgery. Participants in both groups (A \& B) will be asked to bring their remaining postoperative pain medication to their postoperative follow-up appointments for review by study personnel. Participants will also be asked to complete a survey about their knee activity, function and symptoms at these appointments. Your time in the study will last until the completion of the 12-week postoperative follow-up appointment.

What is being tested

• Cryoneurolysis (procedure)

Sponsor: Virtua Health, Inc. · Participants: 20 · Started: Aug 28, 2024

Contact the study team

• Sean Mc Millan, DO · Phone: (609)747-9200

Official record on ClinicalTrials.gov — NCT06603051

Locations in the U.S.

From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.